Multiple device implantation in coronary sinus for functional mitral regurgitation: Which is first?

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 3, 2009, Pages 512-513

  Bertrand, Olivier F ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTIC VALVE REPAIR; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CORONARY SINUS; DEFIBRILLATOR; HEART LEFT VENTRICLE FAILURE; HUMAN; IMPLANTATION; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; NOTE; PATIENT SAFETY; PROSTHESIS FAILURE; STENT; SURGICAL TECHNIQUE; THERAPY EFFECT; CARDIOVERSION; HEART CATHETERIZATION; HEART FAILURE; INSTRUMENTATION; PATHOPHYSIOLOGY; PROSTHESIS; TREATMENT OUTCOME;

CORONARY SINUS; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HEART CATHETERIZATION; HEART FAILURE; HUMANS; MITRAL VALVE INSUFFICIENCY; PROSTHESIS DESIGN; STENTS; TREATMENT OUTCOME;

EID: 70350508232     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22221     Document Type: Note

References (12)

1. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-249.
2. Webb JG. Percutaneous aortic valve replacement will become a common treatment for aortic valve disease. JACC Cardiovasc Interv 2008;1:122-126.
3. Rodes-Cabau J, Dumont E, De LaRochelliere R, et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol 2008;102:1240-1246.
4. Clavel MA, Webb JG, Pibarot P, et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol 2009;53:1883-1891.
5. Masson JB, Webb JG. Percutaneous mitral annuloplasty. Coron Artery Dis 2009;20:183-188.
6. Piazza N, Asgar A, Ibrahim R, Bonan R. Transcatheter mitral and pulmonary valve therapy. J Am Coll Cardiol 2009;53:1837-1851.
7. Webb JG, Harnek J, Munt BI, Kimblad PO, Chandavimol M, Thompson CR, Mayo JR, Solem JO. Percutaneous transvenous mitral annuloplasty: Initial human experience with device implantation in the coronary sinus. Circulation 2006;113:851-855. (Pubitemid 43754306)
8. Sack S, Kahlert P, Bilodeau L, et al. Percutaneous transvenous mitral annuloplasty: Initial human experience with a novel coronary sinus implant device. Circ Cardiovasc Intervent (epub 23, June 2009).
9. Siminiak T, Hoppe U, Schofer J, Haude M, Herrman J, Vainer J, Firek L, Reuter D, Goldberg S, Van Bibber R. Effectiveness and safety of percutaneous coronary sinus-based mitral velver repair in patients with dilated cardiomyopathy (from the AMADEUS trial). Am J Cardiol (epub 29 May 2009).
10. Hunt SA, Abraham WT, Chin MH, et al. Focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1-e90.
11. Lancellotti P, Senechal M, Moonen M, Donal E, Magne J, Nellessen E, Attena E, Cosyns B, Melon P, Pierard L. Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling after cardiac resynchronization therapy. Eur J Echocardiogr2009;10:663-668.
12. Moonen M, Senechal M, Cosyns B, Melon P, Nellessen E, Pierard L, Lancellotti P. Impact of contractile reserve on acute response to cardiac resynchronization therapy. Cardiovasc Ultrasound 2008;6:65-70.